Rossing P - Search Results

1

Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis.

Filippatos G, Anker SD, August P, Coats AJS, Januzzi JL, Mankovsky B, Rossing P, Ruilope LM, Pitt B, Sarafidis P, Teerlink JR, Kapelios CJ, Gebel M, Brinker M, Joseph A, Lage A, Bakris G, Agarwal R. Filippatos G, et al. Among authors: rossing p. Eur Heart J Cardiovasc Pharmacother. 2023 Feb 2;9(2):183-191. doi: 10.1093/ehjcvp/pvad001. Eur Heart J Cardiovasc Pharmacother. 2023. PMID: 36639130 Free PMC article.

2

Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients.

Gall MA, Rossing P, Skøtt P, Damsbo P, Vaag A, Bech K, Dejgaard A, Lauritzen M, Lauritzen E, Hougaard P, et al. Gall MA, et al. Among authors: rossing p. Diabetologia. 1991 Sep;34(9):655-61. doi: 10.1007/BF00400995. Diabetologia. 1991. PMID: 1955098

3

Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study.

Rossing P, Hougaard P, Borch-Johnsen K, Parving HH. Rossing P, et al. BMJ. 1996 Sep 28;313(7060):779-84. doi: 10.1136/bmj.313.7060.779. BMJ. 1996. PMID: 8842069 Free PMC article.

4

Predictors of mortality in patients with type 2 diabetes with or without diabetic nephropathy: a follow-up study.

Astrup AS, Nielsen FS, Rossing P, Ali S, Kastrup J, Smidt UM, Parving HH. Astrup AS, et al. Among authors: rossing p. J Hypertens. 2007 Dec;25(12):2479-85. doi: 10.1097/HJH.0b013e3282f06428. J Hypertens. 2007. PMID: 17984670

5

Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy.

Jorsal A, Tarnow L, Frystyk J, Lajer M, Flyvbjerg A, Parving HH, Vionnet N, Rossing P. Jorsal A, et al. Among authors: rossing p. Kidney Int. 2008 Sep;74(5):649-54. doi: 10.1038/ki.2008.201. Epub 2008 May 21. Kidney Int. 2008. PMID: 18496510 Free article.

6

Evaluation of placental growth factor and soluble Fms-like tyrosine kinase 1 as predictors of all-cause and cardiovascular mortality in patients with Type 1 diabetes with and without diabetic nephropathy.

Theilade S, Lajer M, Jorsal A, Tarnow L, Parving HH, Rossing P. Theilade S, et al. Among authors: rossing p. Diabet Med. 2012 Mar;29(3):337-44. doi: 10.1111/j.1464-5491.2011.03482.x. Diabet Med. 2012. PMID: 21988672

7

[Renal disease by type 2 diabetes].

Persson F, Rossing P. Persson F, et al. Among authors: rossing p. Ugeskr Laeger. 2012 Sep 10;174(37):2150-4. Ugeskr Laeger. 2012. PMID: 22971295 Danish.

8

Levels of NT-proBNP, markers of low-grade inflammation, and endothelial dysfunction during spironolactone treatment in patients with diabetic kidney disease.

Nielsen SE, Schjoedt KJ, Rossing K, Persson F, Schalkwijk CG, Stehouwer CD, Parving HH, Rossing P. Nielsen SE, et al. Among authors: rossing k, rossing p. J Renin Angiotensin Aldosterone Syst. 2013 Jun;14(2):161-6. doi: 10.1177/1470320312460290. Epub 2012 Oct 29. J Renin Angiotensin Aldosterone Syst. 2013. PMID: 23108194 Free article. Clinical Trial.

9

Direct renin inhibition in chronic kidney disease.

Persson F, Rossing P, Parving HH. Persson F, et al. Among authors: rossing p. Br J Clin Pharmacol. 2013 Oct;76(4):580-6. doi: 10.1111/bcp.12072. Br J Clin Pharmacol. 2013. PMID: 23278708 Free PMC article. Review.

10

Improved prognosis of diabetic nephropathy in type 1 diabetes.

Andrésdóttir G, Jensen ML, Carstensen B, Parving HH, Hovind P, Hansen TW, Rossing P. Andrésdóttir G, et al. Among authors: rossing p. Kidney Int. 2015 Feb;87(2):417-26. doi: 10.1038/ki.2014.206. Epub 2014 Jun 11. Kidney Int. 2015. PMID: 24918158 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

788 results

Search Page

Filters